Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
ALZHEIMER'S DISEASE CLINICAL TRIAL

Alzheimer's Disease Clinical Trial

Seeking individuals with mild to moderate symptoms of Alzheimer’s disease to participate in a 24-week research study. Alzheimer's disease is the most common form of dementia, accounting for approximately 50% of patients in the United States with progressive cognitive decline. More than 3.5 million people in the United States have Alzheimer's disease. With the aging of the population, this number continues to grow each year. We are conducting a clinical trial designed to demonstrate whether or not a novel investigational medication alleviates the symptoms associated with Alzheimer's disease.

Eligibility Criteria:

  • Diagnosed with mild to moderate Alzheimer’s disease;
  • Taking a stable dose of an acetylcholinesterase inhibitor (such as Aricept, Reminyl, or Excelon) for 12 weeks;
  • Have a caregiver or study partner available to participate in the assessment of the patient and monitor dosing.
All diagnostic and laboratory evaluations are done at no cost to the subject and study medication is provided at no of charge. Transportation costs during study participation will be reimbursed.

Scheduling Requirements: This study involves twelve clinic visits over 24 weeks. For more information, please contact a site near you:

UCI Irvine Medical Center
Orange, Ca 92868
Phone: (714) 456-6315

Pivotal Research Centers
Peoria, AZ 85381
Phone: (623) 815-9714

Pivotal Research Centers
Mesa, AZ 85210
Phone: (480) 615-3200

Clinical Pharmaceutical Trials, Inc.
Tulsa, Ok 74104
Phone: (918) 743-2349

Pahl Pharmaceutical Research, LLC
Oklahoma City, OK 73118
Phone: (405) 525-6500

California Neuroscience Research Medical Group, Inc.
Sherman Oaks, CA 91403
Phone: (818) 990-2671

Grayline Clinical Drug Trials
Wichita Falls, Texas 76309
Phone: (940) 322-1131 Phone: (800) 782-0895

AVI Clinical Research
Torrance, CA 90505
Phone: (310) 891-1383

Stedman Clinical Trials
3212 Cove Bend Dr.
Tampa, FL 33613
Phone: (813) 971-8311

International Clinical Research Associates
Richmond, VA 23294
Phone: (804) 270-6811

Clinical Trials Research Services
Pittsburgh, PA 15206
Phone: (412) 363-1900

Eastside Medical Research
New York, NY 10021
Phone: (212) 288-0138

Clinical Physiology Associates
Ft. Myers, FL 33916
Phone: (239) 936-4421

Memory Enhancement Center
Long Branch, NJ 07740
Phone: (732)263-0101 Neuro Center of Ohio
Toledo, OH 43623
Phone: (419) 841-7369

Baumel-Eisner Neuromed Inst
Ft. Lauderdale, FL 33321
Phone: (954) 720-1899

Baumel-Eisner Neuromed Inst
Miami Beach, FL 33154
Phone: (305) 865-0063

Baumel-Eisner Neuromed Inst
Boca Raton, 33486
Phone: (561) 368-1123

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad